← Back to Search

Anterior Gastropexy for Hiatal Hernia

N/A
Waitlist Available
Research Sponsored by Clayton Petro
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Crura must be reapproximated at time of surgery
Symptomatic paraesophageal hernia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test whether attaching the stomach to the inner abdominal wall will help prevent paraesophageal hernias from recurring.

Who is the study for?
This trial is for adults over 18 with a symptomatic paraesophageal hernia that's at least 5cm tall, as seen on an upper GI study or endoscopy. They must be able to do follow-ups and are scheduled for elective laparoscopic hernia repair, which can switch to open surgery if needed. It's not for those who've had previous esophagus/stomach surgeries, emergency operations for twisted stomachs, or need a feeding tube or weight-loss related procedures.Check my eligibility
What is being tested?
The study tests whether anterior gastropexy (stitching the stomach to the abdominal wall) prevents paraesophageal hernias from coming back after repair surgery. Participants will be randomly divided into two groups: one receiving gastropexy and the other not, to compare outcomes.See study design
What are the potential side effects?
Potential side effects of anterior gastropexy may include discomfort at the suture site, infection risk from surgical intervention, possible injury to surrounding organs during procedure and complications affecting stomach position.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My surgery will involve stitching the crura together.
Select...
I have symptoms from a hernia near my esophagus.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Paraesophageal Hernia Recurrence
Secondary outcome measures
Mean Change from Baseline in GERD-HRQL Scores at 30 days and 1 year
Mean Change from Baseline in Symptom Severity Measured by Visual Analog Scale at 30 days and 1 year

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention 2 (Treatment)Experimental Treatment1 Intervention
Anterior gastropexy will be performed.
Group II: Intervention 1 (Control)Active Control1 Intervention
No anterior gastropexy will be performed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Anterior Gastropexy
2019
N/A
~240

Find a Location

Who is running the clinical trial?

Clayton PetroLead Sponsor
4 Previous Clinical Trials
1,392 Total Patients Enrolled
The Cleveland ClinicLead Sponsor
1,026 Previous Clinical Trials
1,365,836 Total Patients Enrolled
1 Trials studying Paraesophageal Hernia
164 Patients Enrolled for Paraesophageal Hernia

Media Library

Anterior Gastropexy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04007952 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor still open to recruitment?

"Affirmative. On clinicaltrials.gov, the details of this medical trial confirm that it is currently seeking participants, having first appeared on June 26th 2019 and most recently updated on December 21st 2021. The study aims to recruit 240 patients from a single site."

Answered by AI

What is the estimated number of participants in this research endeavor?

"That is correct. As stated on clinicaltrials.gov, the trial which was first publicized on June 26th 2019 is actively recruiting patients with a targeted enrolment of 240 individuals at one medical centre."

Answered by AI
Recent research and studies
~41 spots leftby Apr 2025